FDA Approved: OCREVUS ZUNOVO — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved the original biologics license application for OCREVUS ZUNOVO (ocrelizumab and hyaluronidase) from Genentech. The product provides a subcutaneous o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• OCREVUS ZUNOVO (ocrelizumab and hyaluronidase)

Snippet

ORIG AP for OCREVUS ZUNOVO (OCRELIZUMAB AND HYALURONIDASE)